Hot Features
Premium
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Period:
Draw Mode:
| Volume | 35 |
|
|||||
| News | - | ||||||
| Day High | Low High |
||||||
| Day Low | |||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Mymetics Corporation (CE) | MYMX | OTCMarkets | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.00 | 0.00% | 0.001 | 19:00:00 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 0.001 | 0.001 |
| Trades | Shares Traded | Average Volume | 52 Week Range |
|---|---|---|---|
| 2 | 35 | - | 0.001 - 56.60 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 14:28:49 | 33 | US$ 0.001 | USD |
Mymetics Corporation (CE) Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 0 | 303.76M | 80.39M | 1.03M | -4.81M | -0.16 | 0.00 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Mymetics (CE) News
| Date | Time | Source | News Article |
|---|---|---|---|
| 1/02/2024 | 12:16 | Edgar (US Regulatory) | Form 15-12G - Securities registration termination [Section.. |
| 12/28/2023 | 07:00 | Edgar (US Regulatory) | Form 8-K - Current report |
| 12/12/2023 | 23:15 | Edgar (US Regulatory) | Form EFFECT - Notice of Effectiveness |
| 11/20/2023 | 07:53 | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
| 10/24/2023 | 15:42 | Edgar (US Regulatory) | Form 8-K - Current report |
| 10/17/2023 | 14:08 | Edgar (US Regulatory) | Form SC 13E3 - Going private transaction by certain issuers |
| 10/11/2023 | 08:00 | Edgar (US Regulatory) | Form 8-K - Current report |
| 8/18/2023 | 05:02 | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
| 7/31/2023 | 16:01 | Edgar (US Regulatory) | Form 8-K - Current report |
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical MYMX Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.001 | 0.001 | 0.001 | 0.001 | 2 | 0.00 | 0.00% |
| 1 Month | 0.001 | 0.001 | 0.001 | 0.001 | 56 | 0.00 | 0.00% |
| 3 Months | 0.001 | 0.001 | 0.001 | 0.001 | 56 | 0.00 | 0.00% |
| 6 Months | 3.70 | 3.70 | 0.001 | 2.91 | 889,331 | -3.70 | -99.97% |
| 1 Year | 17.80 | 56.60 | 0.001 | 3.25 | 825,663 | -17.80 | -99.99% |
| 3 Years | 190.00 | 230.00 | 0.001 | 31.54 | 247,912 | -190.00 | -100.00% |
| 5 Years | 62.40 | 380.00 | 0.001 | 73.92 | 201,057 | -62.40 | -100.00% |
Mymetics (CE) Description
| Mymetics Corporation is US registered biotechnology company with its main offices in Switzerland and the Netherlands. Focused on developing next generation vaccines for infectious and life threatening diseases. Mymetics core technology and expertise are in the use of virosomes, lipid-based carriers containing functional fusion viral proteins in combination with rationally designed antigens and membrane proteins. Mymetics currently has the following vaccines in its pipeline: HIV/AIDS and Covid-19 and collaboration projects in the cancer immunotherapy field. |
